<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endocannabinoid <z:chebi fb="0" ids="2700">anandamide</z:chebi> (AEA) has protective effect on the heart against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury and <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, but the electrophysiological mechanism is unclear yet </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, the sinoatrial node (SAN) samples from New Zealand rabbits were prepared, and intracellular recording technique was used to elucidate the effect of AEA on the action potential (AP) of SAN pacemaker cells of rabbits and the mechanism </plain></SENT>
<SENT sid="2" pm="."><plain>Different concentrations of AEA (1, 10, 100, 200, 500 nmol/L) were applied cumulatively </plain></SENT>
<SENT sid="3" pm="."><plain>For some SAN samples, cannabinoid type 1 (CB1) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> AM251, cannabinoid type 2 (CB2) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> AM630, <z:chebi fb="0" ids="50509">potassium channel blocker</z:chebi> <z:chebi fb="0" ids="44296">tetraethylammonium</z:chebi> (<z:chebi fb="29" ids="28621,35026">TEA</z:chebi>) and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) synthase inhibitor L-<z:chebi fb="13" ids="29785">nitro</z:chebi>-arginine methylester (L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e>) were used before AEA treatment, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>We found that: (1) AEA (100, 200 and 500 nmol/L) not only shortened AP duration (APD), but also decreased AP amplitude (<z:chebi fb="21" ids="53713">APA</z:chebi>) (P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>(2) AM251, but not AM630, abolished the effect of AEA on APD shortening </plain></SENT>
<SENT sid="6" pm="."><plain>(3) <z:chebi fb="29" ids="28621,35026">TEA</z:chebi> and L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> had no influence on the AEA effect </plain></SENT>
<SENT sid="7" pm="."><plain>These findings suggest that <z:chebi fb="0" ids="2700">anandamide</z:chebi> can decrease <z:chebi fb="21" ids="53713">APA</z:chebi> and shorten APD in SAN pacemaker cells of rabbits, which may be mediated by activation of CB1 receptors, and is related to blockade of calcium channels but not <z:chebi fb="120" ids="26216">potassium</z:chebi> channels and NO </plain></SENT>
</text></document>